Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
157.77
+2.84 (1.83%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Employees
Palvella Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 15 or 107.14% compared to the previous year.
Employees
29
Change (1Y)
15
Growth (1Y)
107.14%
Revenue / Employee
n/a
Profits / Employee
-$2,127,448
Market Cap
2.27B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 15 | 107.14% |
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Vericel | 398 |
| Vera Therapeutics | 339 |
| Nuvation Bio | 307 |
| UroGen Pharma | 298 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Rapport Therapeutics | 84 |
PVLA News
- 4 days ago - Palvella Therapeutics price target lowered to $207 from $210 at Truist - TheFly
- 4 days ago - Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - GlobeNewsWire
- 4 days ago - Palvella Therapeutics price target raised to $232 from $227 at Canaccord - TheFly
- 5 days ago - Palvella Therapeutics reports Q2 EPS ($1.52), consensus ($1.15) - TheFly
- 5 days ago - Palvella Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Palvella Therapeutics Earnings release: Q2 2026 - Filings
- 5 days ago - Palvella Therapeutics Quarterly report: Q2 2026 - Filings
- 5 days ago - Palvella Therapeutics Slides: Q2 2026 - Filings